Pain medicine

Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients

JAMA Netw OpenPublished Cohort study subgroup analysis

Primary result · Naloxone boluses in-hospitalResult — go to the resultCohen d 0.78

Authors' conclusion

In this cohort study of patients admitted to the ED with confirmed opioid overdose testing positive for NPOs, in-hospital naloxone dosing was high compared with patients who tested positive for fentanyl alone.

Study context

Population
Adults in the emergency department (ED) with presumed acute opioid overdose (OD) and residual blood samples, ToxIC Fentalog cohort, 2020 to 2022537 with complete laboratory data
Participants
717 adults
Comparison
NPO-positive vs fentanyl-only overdose
  • NPOn = 9
  • Fentanyln = 11reference
Primary endpoint
Total number of naloxone doses and total cumulative naloxone dose administered in routine clinical care after the OD
Methodological detailsnationwide, ongoing cohort (ToxIC Fentalog)
  • Nationwide
  • Ongoing cohort (ToxIC Fentalog)

Primary result

Naloxone boluses in-hospital

Cohen d

0.78

P = 0.02

By group

NPO

1.33

mean · SD 1.50

Fentanyl

0.36

mean · SD 0.92

As reported in the abstract

Further findings

OutcomeValues
Naloxone doses, metonitazene cases (subgroup)Metonitazene mean 3.0 (SD 0)

Naloxone doses, metonitazene cases (subgroup)

Metonitazene OD associated with cardiac arrest and more naloxone doses overall

Safety

OutcomeValues
CPR, metonitazene overdosesMetonitazene 100%
  • CPR, metonitazene overdoses: 2 of 2 patients

Original publication

Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients. JAMA Netw Open. Published 1 August 2023. doi:10.1001/jamanetworkopen.2023.31264

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.